Labcorp Holdings (LH) is back on investors’ radar after recent trading, with the stock closing at $253.18. With mixed short term returns and longer term gains, the company’s laboratory services profile is drawing fresh attention.

Recent trading reflects that pattern, with a 1 day share price return of 0.60% and a 90 day share price return decline of 8.77%, while the 1 year total shareholder return of 8.88% points to steadier longer term momentum.

If Labcorp’s moves have you thinking about the wider healthcare space, this could be a good moment to scan other healthcare stocks that might fit your watchlist.

With Labcorp posting revenue of US$13.77b, net income of US$855.2m, and an intrinsic discount estimate of 55.94%, the key question is whether the stock still trades below its worth or if the market already prices in future growth.

Most Popular Narrative: 15.5% Undervalued

With Labcorp’s last close at US$253.18 against a narrative fair value of roughly US$300, the current gap hinges on earnings, margins and cash flows.

The introduction of innovative tests in oncology, women's health, autoimmune disease, and neurology is anticipated to capture more test volume and outpace growth in the broader market, positively impacting revenue and earnings.

Want to know what kind of revenue run rate and margin profile would support that higher value? The narrative leans on healthier profitability, steadier growth and a future earnings multiple that assumes investors stay comfortable paying up for this mix. Curious how those moving parts fit together to reach a fair value around US$300 per share?

Result: Fair Value of $299.71 (UNDERVALUED)

However, this depends on risks related to tariffs and regulatory changes, as well as potential PAMA impacts on Medicare pricing that could pressure Labcorp’s revenue and margins.

Build Your Own Labcorp Holdings Narrative

If you see the numbers differently or prefer to crunch them yourself, you can shape your own Labcorp story in just a few minutes: Do it your way.

A great starting point for your Labcorp Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If you stop with just one stock, you could miss opportunities that fit your style even better. Put the Screener to work for you today.

• Spot potential value setups by checking out these 877 undervalued stocks based on cash flows, built on cash flow assumptions and current pricing.
• Tap into the AI theme by scanning these 25 AI penny stocks, which focus on artificial intelligence applications across sectors.
• Strengthen your income watchlist with these 14 dividend stocks with yields > 3%, which currently offer yields above 3%.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.